Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 36882524)

  • 1. C4orf19 inhibits colorectal cancer cell proliferation by competitively binding to Keap1 with TRIM25 via the USP17/Elk-1/CDK6 axis.
    Huang S; Li J; Wu S; Zheng Z; Wang C; Li H; Zhao L; Zhang X; Huang H; Huang C; Xie Q
    Oncogene; 2023 Apr; 42(17):1333-1346. PubMed ID: 36882524
    [TBL] [Abstract][Full Text] [Related]  

  • 2. TRIM25 promotes the cell survival and growth of hepatocellular carcinoma through targeting Keap1-Nrf2 pathway.
    Liu Y; Tao S; Liao L; Li Y; Li H; Li Z; Lin L; Wan X; Yang X; Chen L
    Nat Commun; 2020 Jan; 11(1):348. PubMed ID: 31953436
    [TBL] [Abstract][Full Text] [Related]  

  • 3. TRIM25 promotes temozolomide resistance in glioma by regulating oxidative stress and ferroptotic cell death via the ubiquitination of keap1.
    Wei J; Wang L; Zhang Y; Sun T; Zhang C; Hu Z; Zhou L; Liu X; Wan J; Ma L
    Oncogene; 2023 Jun; 42(26):2103-2112. PubMed ID: 37188737
    [TBL] [Abstract][Full Text] [Related]  

  • 4. LINC00955 suppresses colorectal cancer growth by acting as a molecular scaffold of TRIM25 and Sp1 to Inhibit DNMT3B-mediated methylation of the PHIP promoter.
    Ren G; Li H; Hong D; Hu F; Jin R; Wu S; Sun W; Jin H; Zhao L; Zhang X; Liu D; Huang C; Huang H
    BMC Cancer; 2023 Sep; 23(1):898. PubMed ID: 37742010
    [TBL] [Abstract][Full Text] [Related]  

  • 5. JP3, an antiangiogenic peptide, inhibits growth and metastasis of gastric cancer through TRIM25/SP1/MMP2 axis.
    Chen JJ; Ren YL; Shu CJ; Zhang Y; Chen MJ; Xu J; Li J; Li AP; Chen DY; He JD; Shu YQ; Zhou JW
    J Exp Clin Cancer Res; 2020 Jun; 39(1):118. PubMed ID: 32576271
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epigenetic modifications but not genetic polymorphisms regulate KEAP1 expression in colorectal cancer.
    Gao L; Yuan F; Che G; Xiao X; Nie X; Wang Y; Jia J; Kong AN; Zhang L
    J Cell Biochem; 2019 Aug; 120(8):12311-12320. PubMed ID: 30825237
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nrf2/P-glycoprotein axis is associated with clinicopathological characteristics in colorectal cancer.
    Sadeghi MR; Jeddi F; Soozangar N; Somi MH; Shirmohamadi M; Khaze V; Samadi N
    Biomed Pharmacother; 2018 Aug; 104():458-464. PubMed ID: 29793178
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Blockade of miR-3614 maturation by IGF2BP3 increases TRIM25 expression and promotes breast cancer cell proliferation.
    Wang Z; Tong D; Han C; Zhao Z; Wang X; Jiang T; Li Q; Liu S; Chen L; Chen Y; Li A; Huang C
    EBioMedicine; 2019 Mar; 41():357-369. PubMed ID: 30797711
    [TBL] [Abstract][Full Text] [Related]  

  • 9. E3 ligase TRIM15 facilitates non-small cell lung cancer progression through mediating Keap1-Nrf2 signaling pathway.
    Liang M; Wang L; Sun Z; Chen X; Wang H; Qin L; Zhao W; Geng B
    Cell Commun Signal; 2022 May; 20(1):62. PubMed ID: 35534896
    [TBL] [Abstract][Full Text] [Related]  

  • 10. TRIM16 overexpression inhibits the metastasis of colorectal cancer through mediating Snail degradation.
    Ruan L; Liu W; Yang Y; Chu Z; Yang C; Yang T; Sun J
    Exp Cell Res; 2021 Sep; 406(1):112735. PubMed ID: 34265287
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The ubiquitin ligase TRIM25 inhibits hepatocellular carcinoma progression by targeting metastasis associated 1 protein.
    Zang HL; Ren SN; Cao H; Tian XF
    IUBMB Life; 2017 Oct; 69(10):795-801. PubMed ID: 28861931
    [TBL] [Abstract][Full Text] [Related]  

  • 12. ATAD2 drives colorectal cancer progression by regulating TRIM25 expression via a positive feedback loop with E2F transcriptional factors.
    Tong Y; Li J; Peng M; Qian Q; Shi W; Chen Z; Liu B
    Biochem Biophys Res Commun; 2022 Feb; 594():146-152. PubMed ID: 35085891
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tripartite motif containing 25 promotes proliferation and invasion of colorectal cancer cells through TGF-β signaling.
    Sun N; Xue Y; Dai T; Li X; Zheng N
    Biosci Rep; 2017 Aug; 37(4):. PubMed ID: 28620119
    [TBL] [Abstract][Full Text] [Related]  

  • 14. TRIM22 inhibits osteosarcoma progression through destabilizing NRF2 and thus activation of ROS/AMPK/mTOR/autophagy signaling.
    Liu W; Zhao Y; Wang G; Feng S; Ge X; Ye W; Wang Z; Zhu Y; Cai W; Bai J; Zhou X
    Redox Biol; 2022 Jul; 53():102344. PubMed ID: 35636015
    [TBL] [Abstract][Full Text] [Related]  

  • 15. UBR5 Contributes to Colorectal Cancer Progression by Destabilizing the Tumor Suppressor ECRG4.
    Wang J; Zhao X; Jin L; Wu G; Yang Y
    Dig Dis Sci; 2017 Oct; 62(10):2781-2789. PubMed ID: 28856538
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dihydrotanshinone I inhibits ovarian tumor growth by activating oxidative stress through Keap1-mediated Nrf2 ubiquitination degradation.
    Sun C; Han B; Zhai Y; Zhao H; Li X; Qian J; Hao X; Liu Q; Shen J; Kai G
    Free Radic Biol Med; 2022 Feb; 180():220-235. PubMed ID: 35074488
    [TBL] [Abstract][Full Text] [Related]  

  • 17. De-ubiquitination of ELK-1 by USP17 potentiates mitogenic gene expression and cell proliferation.
    Ducker C; Chow LKY; Saxton J; Handwerger J; McGregor A; Strahl T; Layfield R; Shaw PE
    Nucleic Acids Res; 2019 May; 47(9):4495-4508. PubMed ID: 30854565
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The deubiquitinase USP10 restores PTEN activity and inhibits non-small cell lung cancer cell proliferation.
    He Y; Jiang S; Mao C; Zheng H; Cao B; Zhang Z; Zhao J; Zeng Y; Mao X
    J Biol Chem; 2021 Sep; 297(3):101088. PubMed ID: 34416231
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gene-expression signature regulated by the KEAP1-NRF2-CUL3 axis is associated with a poor prognosis in head and neck squamous cell cancer.
    Namani A; Matiur Rahaman M; Chen M; Tang X
    BMC Cancer; 2018 Jan; 18(1):46. PubMed ID: 29306329
    [TBL] [Abstract][Full Text] [Related]  

  • 20. TRIM47 is up-regulated in colorectal cancer, promoting ubiquitination and degradation of SMAD4.
    Liang Q; Tang C; Tang M; Zhang Q; Gao Y; Ge Z
    J Exp Clin Cancer Res; 2019 Apr; 38(1):159. PubMed ID: 30979374
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.